Join
Live feed
·
NEWSReleasevia Quantisnow
Evotec SE logo

Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

ByQuantisnow·Wall Street's wire, on your screen.
EVO· Evotec SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVO (Evotec SE) and more on Quantisnow.